Health 
   Mental Health & Neurology
Medical Treatment & Drug Development
Newborn & Babies
Brain Mechanisms & Psychology
Post-Doctoral Fellowships
Italy
Neonatal jaundice: In vivo bilirubin neurotoxicity in a Ugt1 ko mouse model
 75% of hospital readmissions of babies in their first week of life are due to jaundice. Severe jaundice can lead to permanent neurological damage and ultimately death. Limitations in animal and cellular models have narrowed the study of this disease. Thanks to a mutant mouse model that more closely mimics human jaundice, Dr. Guilia Bortolussi is performing molecular, tissue and behavioral analysis to better understand the molecular mechanisms that damage the brain and testing therapies that could improve brain protection. 
 Jaundice and babies
To add or modify information on this page, please contact us at the following address: community.research@axa.com
 Giulia
 BORTOLUSSI 
Institution
International Centre for Genetic Engineering and Biotechnology
Country
Italy
Nationality
Italian
Related articles
 Health 
   Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
 Celine
 GRECO